EviCore updates its insurance coverage guidelines to reimburse AI software for analyzing coronary CT angiography (CCTA) images.
Key Details
- 1EviCore now recommends reimbursement for AI-based CCTA analysis from Cleerly, Heartflow, and Elucid.
- 2Guidelines apply to acute or stable chest pain patients and those with noted coronary stenoses.
- 3Policy takes effect October 1, 2024.
- 4Follows Medicare's recent approval and expanded payment for AI-backed CCTA analyses, now covering over 70% of Medicare patients.
- 5CMS doubled hospital/outpatient reimbursement for cardiac CT scans to $357.13 as of January 2024.
Why It Matters
Expanded payer coverage accelerates the clinical adoption of AI-powered CCTA, increasing access and incentives for hospitals to implement these advanced tools, which can aid early detection and personalized treatment for cardiac patients.
Source
Radiology Business
Related News
•Radiology Business
AI Outperforms Radiologists in Predicting Lung Cancer Treatment Response
AI tools demonstrate higher accuracy than radiologists in predicting lung cancer treatment response from imaging studies.
•AI in Healthcare
Key Advances and Cautions in Healthcare AI for Imaging and Clinical Workflows
Healthcare AI is advancing rapidly with new tools enhancing efficiency and effectiveness, but integration challenges and bias mitigation remain crucial, especially in imaging.
•AuntMinnie
LLMs Demonstrate Strong Potential in Interventional Radiology Patient Education
DeepSeek-V3 and ChatGPT-4o excelled in accurately answering patient questions about interventional radiology procedures, suggesting LLMs' growing role in clinical communication.